Month: March 2025

Edgewise Therapeutics to Host Webcast Event to Discuss Top-Line Results from Phase 2 CIRRUS-HCM 28-Day Trial of EDG-7500 in Hypertrophic Cardiomyopathy (HCM) on Wednesday, April 2 at 8:30 am Eastern Time

BOULDER, Colo., March 26, 2025 /PRNewswire/ -- Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced...

uLab®, Ortho-Automation, and Voxel Dental Collaborate to Provide Dental Professionals with Innovative In-Office Aligner Solutions and Greater Workflow Efficiency

MEMPHIS, Tenn., March 26, 2025 /PRNewswire/ -- uLab Systems® announces a new strategic collaboration with Ortho-Automation and Voxel Dental, two...

error: Content is protected !!